BLOG

pharma's almanac

Applying A Synthetic Approach To The Development Of A New Generation Of Antibiotics

Australian company Recce Pharmaceuticals (ASX: RCE) is advancing a synthetic polymer antibiotic designed with optimum properties that exhibits high potency against a broad range of bacteria.